28 related articles for article (PubMed ID: 1711079)
1. Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis.
Wu CC; Chen MS; Cheng YJ; Ko YC; Lin SF; Chiu IM; Chen JY
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31731581
[TBL] [Abstract][Full Text] [Related]
2. Therapies based on targeting Epstein-Barr virus lytic replication for EBV-associated malignancies.
Li H; Hu J; Luo X; Bode AM; Dong Z; Cao Y
Cancer Sci; 2018 Jul; 109(7):2101-2108. PubMed ID: 29751367
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation.
Fukuda M; Longnecker R
J Virol; 2005 Jul; 79(13):8655-60. PubMed ID: 15956608
[TBL] [Abstract][Full Text] [Related]
4. Identification of protein tyrosine kinases required for B-cell- receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter.
Lavens S; Faust EA; Lu F; Jacob M; Leta M; Lieberman PM; Puré E
J Virol; 2004 Aug; 78(16):8543-51. PubMed ID: 15280463
[TBL] [Abstract][Full Text] [Related]
5. Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients.
Nagata Y; Inoue H; Yamada K; Higashiyama H; Mishima K; Kizu Y; Takeda I; Mizuno F; Hayashi Y; Saito I
Immunology; 2004 Feb; 111(2):223-9. PubMed ID: 15027908
[TBL] [Abstract][Full Text] [Related]
6. Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from Latency.
Bryant H; Farrell PJ
J Virol; 2002 Oct; 76(20):10290-8. PubMed ID: 12239305
[TBL] [Abstract][Full Text] [Related]
7. Complete nucleotide sequence of bean pod mottle virus RNA1: sequence comparisons and evolutionary relationships to other comoviruses.
Di R; Hu CC; Ghabrial SA
Virus Genes; 1999; 18(2):129-37. PubMed ID: 10403699
[TBL] [Abstract][Full Text] [Related]
8. The interaction of mitogen-activated protein kinases to Epstein-Barr virus activation in Akata cells.
Satoh T; Hoshikawa Y; Satoh Y; Kurata T; Sairenji T
Virus Genes; 1999; 18(1):57-64. PubMed ID: 10334038
[TBL] [Abstract][Full Text] [Related]
9. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.
Miller CL; Lee JH; Kieff E; Longnecker R
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):772-6. PubMed ID: 8290598
[TBL] [Abstract][Full Text] [Related]
10. Predominant expression and activation-induced tyrosine phosphorylation of phospholipase C-gamma 2 in B lymphocytes.
Coggeshall KM; McHugh JC; Altman A
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5660-4. PubMed ID: 1376928
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
Daibata M; Speck SH; Mulder C; Sairenji T
Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228
[TBL] [Abstract][Full Text] [Related]
12. [The mechanisms of Epstein-Barr virus activation in B cells].
Sairenji T
Nihon Rinsho; 1997 Feb; 55(2):316-20. PubMed ID: 9046817
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of protein tyrosine phosphorylation in endothelial cells: relationship to antiproliferative action of genistein.
Koroma BM; de Juan E
Biochem Soc Trans; 1997 Feb; 25(1):35-40. PubMed ID: 9056839
[No Abstract] [Full Text] [Related]
14. Effect of genistein, a tyrosine kinase inhibitor, on latent EBV activation induced by cross-linkage of membrane IgG in Akata B cells.
Daibata M; Mellinghoff I; Takagi S; Humphreys RE; Sairenji T
J Immunol; 1991 Jul; 147(1):292-7. PubMed ID: 1711079
[TBL] [Abstract][Full Text] [Related]
15. Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata.
Daibata M; Humphreys RE; Takada K; Sairenji T
J Immunol; 1990 Jun; 144(12):4788-93. PubMed ID: 2161880
[TBL] [Abstract][Full Text] [Related]
16. The role of tyrosine phosphorylation in signal transduction through surface Ig in human B cells. Inhibition of tyrosine phosphorylation prevents intracellular calcium release.
Lane PJ; Ledbetter JA; McConnell FM; Draves K; Deans J; Schieven GL; Clark EA
J Immunol; 1991 Jan; 146(2):715-22. PubMed ID: 1702814
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
